Displaying drugs 26 - 50 of 12626 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Sinapultide | 2469.45 C126H238N26O22 |  | A synthetic lung surfactant used to treat infant respiratory distress syndrome. | Pulmonary Surfactants |
| Modimelanotide | 2433.96 C113H181N33O25S |  | Modimelanotide is under investigation in clinical trial NCT01897519 (A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High... | Pyridines |
| DiaPep 277 | 2390.768 C106H180N28O34 |  | Investigated for use/treatment in diabetes mellitus type 1, autoimmune diseases, and diabetes mellitus type 2. | Diabetes Mellitus, Type 1 |
| GO-203-2C | 2352.8 C89H170N52O20S2 |  | GO-203-2C is under investigation in clinical trial NCT02204085 (A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia). | Not Annotated |
| Edratide | 2309.574 C111H149N27O28 |  | Edratide is under investigation in clinical trial NCT00203151 (A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus). | Amino Acids, Peptides, and Proteins / Antibodies / Blood Proteins / Globulins / Immunoproteins / Peptides / Proteins / Serum Globulins |
| Escin | 2262.538 C110H172O48 |  | An anti-inflammatory and vasoconstrictive agent indicated to treat minor muscle and joint trauma. | Cardiovascular Agents / Pentacyclic Triterpenes / Saponins |
| PP-F11N lutetium Lu-177 | 2204.992 C90H120LuN19O35 |  | Not Annotated | Not Annotated |
| Bivalirudin | 2180.2853 C98H138N24O33 |  | A direct thrombin inhibitor used to treat heparin-induced thrombocytopenia and to prevent thrombosis during percutaneous coronary intervention. | Anticoagulants / Antithrombins |
| Dynorphin | 2147.523 C99H155N31O23 |  | Dynorphin is under investigation in clinical trial NCT00000244 (Effects of Dynorphin 1-13 on Heroin Addiction - 1). | Neurotransmitter Agents / Opioid Peptides |
| Vasopressin | 2140.46 C92H130N28O24S4 |  | A peptide hormone used to increase blood pressure in patients with vasodilatory shock who are resistant to fluid and catecholamine therapy. | Vasopressin and Analogues |
| MALP-2 | 2135.59 C99H167N19O30S |  | Not Annotated | Macrophage Activation |
| Alsactide | 2119.57 C99H155N29O21S |  | Not Annotated | Tests for Renal Function and Ureteral Injuries |
| Mibenratide | 2097.27 C87H129N27O30S2 |  | Mibenratide is under investigation in clinical trial NCT01798745 (A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies). | Amino Acids, Peptides, and Proteins / Peptides |
| Sodium ferric gluconate complex | 2089.309 C66H121Fe2NaO65 |  | An iron complex used for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. | Parenteral Iron Replacement |
| Avicin D | 2083.279 C98H155NO46 |  | Not Annotated | Carbohydrates / Glycosides |
| Hexatantalum Dodecabromide | 2055.623 Br12H11Ta6 |  | Not Available | Not Available |
| Lancovutide | 2013.3 C89H125N23O25S3 |  | Investigated for use/treatment in cystic fibrosis and eye disorders/infections. | Amino Acids, Peptides, and Proteins / Peptides |
| Sugammadex | 2002.12 C72H112O48S8 |  | A modified gamma cyclodextrin used to reverse neuromuscular blockade induced by vecuronium bromide and rocuronium bromide which are agents used for anesthesia. | Antidotes / gamma-Cyclodextrins |
| DOTA-Arg-Pro-Lys-Pro-Gln-Gln-Phe-2Thi-Gly-Leu-Met(O2)-NH2 Actinium AC-225 | 1994.07 C77H119AcN22O22S2 |  | Not Annotated | Not Annotated |
| Cefilavancin | 1983.27 C87H95Cl3N16O28S2 |  | Investigated for use/treatment in bacterial infection, skin infections/disorders, and staph bacterial infections. | Amides / Amino Acids, Peptides, and Proteins / beta-Lactams / Carbohydrates / Glycoconjugates / Glycopeptides / Heterocyclic Compounds, Fused-Ring / Lactams / Peptides / Sulfur Compounds / Thiazines |
| CBP-501 | 1929.1 C86H122F5N29O17 |  | Not Annotated | Amino Acids, Peptides, and Proteins / Cell Cycle Proteins / Dual-Specificity Phosphatases / Enzymes / Enzymes and Coenzymes / Esterases / Hydrolases / Intracellular Signaling Peptides and Proteins / Multifunctional Enzymes / Peptides / Phosphoprotein Phosphatases / Phosphoric Monoester Hydrolases / Protein Tyrosine Phosphatases / Proteins |
| CTCE-9908 | 1927.288 C86H147N27O23 |  | Investigated for use/treatment in cancer/tumors (unspecified), lung cancer, and sarcoma. | Amino Acids, Peptides, and Proteins |
| Vintafolide | 1917.06 C86H109N21O26S2 |  | Investigated for use/treatment in solid tumors. | Vinca Alkaloids |
| Nerofe | 1897.215 C96H129N21O20 |  | Nerofe is under investigation in clinical trial NCT03059615 (A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS). | Amino Acids, Peptides, and Proteins |
| Zoptarelin doxorubicin | 1893.044 C91H117N19O26 |  | Zoptarelin doxorubicin has been used in trials studying the treatment of Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, and Urothelial Carcinoma, among others. | Amino Acids, Peptides, and Proteins / Anthracyclines / Carbohydrates / Glycosides / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / Hypothalamic Hormones / Naphthacenes / Nerve Tissue Proteins / Neuropeptides / Oligopeptides / Peptide Hormones / Peptides / Pituitary Hormone-Releasing Hormones / Proteins |
Displaying drugs 26 - 50 of 12626 in total